Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry
F Yashima, M Hara, T Inohara, M Jinzaki, H Shimizu… - BMJ open, 2021 - bmjopen.bmj.com
Objective Data on statin for patients with aortic stenosis (AS) who underwent transcatheter
aortic valve implantation (TAVI) are limited. The present study aimed to evaluate the impact …
aortic valve implantation (TAVI) are limited. The present study aimed to evaluate the impact …
Time-Course Atherogenic Blood Lipid Response to Statin Discontinuation in Dyslipidemic Adults
L Alvarez-Jimenez, F Morales-Palomo… - Nutrition, Metabolism …, 2024 - Elsevier
Abstract Background and Aims Half of dyslipidemic patients sometimes discontinue statin
medication. It is unclear if blood atherogenic risk increases right after statin discontinuation …
medication. It is unclear if blood atherogenic risk increases right after statin discontinuation …
[HTML][HTML] Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention
F Mazhar, P Hjemdahl, A Sjölander, T Kahan… - American Heart …, 2024 - Elsevier
Background The effectiveness of lipid-lowering therapy (LLT) for primary prevention of
atherosclerotic cardiovascular disease (ASCVD) in routine care may depend on treatment …
atherosclerotic cardiovascular disease (ASCVD) in routine care may depend on treatment …
Statin Intolerance: A Review and Update
Y Tsushima, B Hatipoglu - Endocrine Practice, 2023 - Elsevier
Objective To review the evidence of existing literature on the management of statin
intolerance. Methods We searched for literature pertaining to statin intolerance and …
intolerance. Methods We searched for literature pertaining to statin intolerance and …
Statin intolerance: an overview for clinicians
Lipid disorders are the most common risk factor for atherosclerotic cardiovascular disease
(ASCVD). Statins are the gold standard in the treatment of lipid disorders. These drugs …
(ASCVD). Statins are the gold standard in the treatment of lipid disorders. These drugs …
Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review
A Higashiyama, S Kohsaka… - Journal of Atherosclerosis …, 2024 - jstage.jst.go.jp
In 2022, the Japan Atherosclerosis Society (JAS) updated its prevention guidelines, the
“Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic …
“Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic …
[HTML][HTML] A Look at Primary and Secondary Prevention in the Elderly: The Two Sides of the Same Coin
MG Abrignani, F Lucà, V Abrignani, G Pelaggi… - Journal of Clinical …, 2024 - mdpi.com
The global population is experiencing an aging trend; however, this increased longevity is
not necessarily accompanied by improved health in older age. A significant consequence of …
not necessarily accompanied by improved health in older age. A significant consequence of …
Estimated pulse wave velocity as a predictor of all-cause and cardiovascular mortality in patients with hypertension in China: a prospective cohort study
Y Shi, C Yu, W Zhou, T Wang, L Zhu, H Bao… - Frontiers in …, 2024 - frontiersin.org
Background Whether the estimated pulse wave velocity (ePWV) in Chinese patients with
hypertension can serve as an independent predictor of cardiovascular and all-cause …
hypertension can serve as an independent predictor of cardiovascular and all-cause …
Association between statins prescribed for primary and secondary prevention and major adverse cardiac events among older adults with frailty: a systematic review
M Hale, H Zaman, D Mehdizadeh, O Todd… - Drugs & Aging, 2020 - Springer
Background Statins reduce the risk of major adverse cardiovascular events (MACE),
however their clinical benefit for primary and secondary prevention among older adults with …
however their clinical benefit for primary and secondary prevention among older adults with …
Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008-March 2018
CA Panozzo, LH Curtis, J Marshall, L Fine, BL Wells… - PLoS …, 2019 - journals.plos.org
Background Data from randomized controlled trials and observational studies on older
adults who take statins for primary prevention of atherosclerotic cardiovascular disease are …
adults who take statins for primary prevention of atherosclerotic cardiovascular disease are …